XLO
Xilio Development Inc
NASDAQ: XLO · HEALTHCARE · BIOTECHNOLOGY
$7.92
+1.67% today
Updated 2026-04-30
Market cap
$45.80M
P/E ratio
—
P/S ratio
1.05x
EPS (TTM)
$-4.19
Dividend yield
—
52W range
$6 – $17
Volume
0.2M
Xilio Development Inc (XLO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-80.00%
Operating margin
-86.50%
ROE
-132.50%
ROA
-23.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-17.31M | — | — | — |
| 2020 | $0.00 | $-55.22M | — | — | — |
| 2021 | $0.00 | $-74.30M | — | — | — |
| 2022 | $0.00 | $-87.30M | — | — | — |
| 2023 | $0.00 | $-76.40M | — | — | — |
| 2024 | $6.34M | $-58.24M | 100.00% | -954.95% | -918.05% |
| 2025 | $43.77M | $-35.04M | 96.48% | -95.92% | -80.05% |